We are live on ! Find out more
APLT

Applied Therapeutics
APLT

Delisted

APLT was delisted on the 2nd of February, 2026.

Back to rankings

38 hedge funds and large institutions have $15.1M invested in Applied Therapeutics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6.27% less ownership

Funds ownership: 47.22% → 40.95% (-6.3%)

12% less capital invested

Capital invested by funds: $17.1M → $15.1M (-$2.07M)

14% less funds holding

Funds holding: 44 → 38 (-6)

55% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 11

67% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 18

Holders
38
Holders Change
-6
Holders Change %
-13.64%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
6
Reduced
18
Closed
11
Calls
$85K
Puts
–
Net Calls
+$85K
Net Calls Change
-$4.06M

Top Buyers

Rank Fund Capital Flow
1
KCM
Knoll Capital Management
Florida
+$1.08M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$272K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$256K
4
PVI
Pura Vida Investments
New York
+$80.4K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$22.9K

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.54M
2
O
OrbiMed
New York
-$948K
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$791K
4
BlackRock
BlackRock
New York
-$185K
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$183K
Name Holding Trade Value Shares
Change 		Change in
Stake
PIA
26
Perennial Investment Advisors
California
$8.82K – – –
UBS Group
27
UBS Group
Switzerland
$8.64K -$12.5K -15,781 -58%
TSS
28
Two Sigma Securities
New York
$8.31K +$8.65K +10,933 New
TRCT
29
Tower Research Capital (TRC)
New York
$4K -$4.25K -5,368 -51%
Morgan Stanley
30
Morgan Stanley
New York
$3.41K -$12.3K -15,597 -78%
BNP Paribas Financial Markets
31
BNP Paribas Financial Markets
France
$2.37K +$1.96K +2,481 +388%
Group One Trading
32
Group One Trading
Illinois
$825 – – –
Citadel Advisors
33
Citadel Advisors
Florida
$284 +$296 +374 New
Citigroup
34
Citigroup
New York
$223 -$80.4K -101,652 -100%
Wells Fargo
35
Wells Fargo
California
$204 +$6 +7 +3%
Bank of America
36
Bank of America
North Carolina
$98 -$260 -329 -72%
FDCDDQ
37
Federation des caisses Desjardins du Quebec
Quebec, Canada
$64 – – –
First Manhattan
38
First Manhattan
New York
– -$68K -73,783 Closed
MS
39
Maven Securities
Jersey
– -$47K -50,000 Closed
HF
40
HRT Financial
New York
– -$26K -28,380 Closed
Goldman Sachs
41
Goldman Sachs
New York
– -$26K -28,321 Closed
Qube Research & Technologies (QRT)
42
Qube Research & Technologies (QRT)
United Kingdom
– -$14K -15,060 Closed
Man Group
43
Man Group
United Kingdom
– -$10K -11,287 Closed
CSS
44
Cubist Systematic Strategies
Connecticut
– -$4K -4,038 Closed
JP Morgan Chase
45
JP Morgan Chase
New York
– -$1.3K -1,646 -81%
1
2

APLT Hedge Fund Activity: Q4 2022 in Review

38 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q4 2022, worth a combined $15.1M — down 12% from $17.1M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of APLT and 5 opened new positions — a net loss of 6 holders — while 18 trimmed existing stakes and 6 added.

The largest buyer was Knoll Capital Management, adding an estimated $1.08M. The largest seller was Alyeska Investment Group, cutting an estimated $1.54M.

  • 38 institutional investors held Applied Therapeutics (APLT) as of Q4 2022, down from 44 in Q3 2022.
  • Funds reported $15.1M of Applied Therapeutics stock for Q4 2022, down 12% quarter-over-quarter.
  • 5 funds opened new Applied Therapeutics positions in Q4 2022 and 11 closed out, a net change of -6 holders.
  • The largest Applied Therapeutics buyer in Q4 2022 was Knoll Capital Management, an estimated $1.08M added.
  • The largest Applied Therapeutics seller in Q4 2022 was Alyeska Investment Group, an estimated $1.54M sold.

Based on aggregated 13F filings for Q4 2022.